• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    This invention concerns compounds showing activity as histamine H2-receptor antagonists. The compounds of the invention are of Structure where Het is a substituted or unsubstituted, fully-unsaturated 5- or 6- membered heterocycle containing at least one nitrogen atom, or a furan or thiophene ring substituted by a substituted or unsubstituted aminoalkyl group; Z is sulphur, methylene or oxygen; m is 0, 1 or 2, n is 2 or 3 with m + n being 3 or 4; and B is a substituted or unsubstituted alkanediyl group or a 2-substituted-2-aza-1,3-propanediyl group; and acid addition salts thereof. The compounds of the invention can be prepared by reacting a compound of formula Het(CH2)mZ(CH2)nNH2 or Het(CH2)mY (where Y is a group displaceable by a mercaptan) with an appropriate 2-subst)tuted-3-nitro-heterocyde. The compositions of the invention contain at least one compound of the invention and a pharmaceutical carrier.
    公开号:SU888815A3
    申请号:SU792772964
    申请日:1979-05-29
    公开日:1981-12-07
    发明作者:Лоренс Роунтри Майкл；Кристофер Янг Родни
    申请人:Смит Клайн Энд Френч Лабораториз Лимитед；
    IPC主号:
    专利说明:

    (54) METHOD FOR OBTAINING NITROCOMPOUNDS
    one
    This invention relates to a process for the preparation of new nitro compounds of the general formula
    Ojlf /
    one
    Het-CfT2-e (JH2) 2HN
    n where Het is imidazole substituted by lower alkyl; B - 1,2-ethanediyl, 1,3-propandiyl or 2-aza-1, 3-propandiyl of the formula -. , where R is benzyl, which can be used in the chemical and pharmaceutical industry. The interaction of thioesters with amines is known 1. The purpose of the invention is to obtain new nitro compounds with valuable pharmaceutical properties. To achieve the goal of obtaining nitro compounds of formula (1), the compound of general formula
    Het - CHji-S- (CHQ) NH (,
    wherein the value of Het is given above, is reacted with a compound of the general formula
    )
    (and)
    权利要求:
    Claims (1)
    [1]
    where X is a QS group, in which Q is lower alkyl, and B values are given above, and the target product is isolated. The reaction is preferably carried out in the presence of an organic solvent, for example, a lower alkanol or pyridine, with heating, for example at the boil. Intermediate compounds of general formula (II) in which X is a group of iS, B is 1,2-ethanediyl or 1,3-propane, diyl are prepared using the following sequence of reactions. l Г ifHB-Kal 0, Ж Q $ X - the QS group is introduced into the reaction with a compound of the formula where Hal is chlorine, bromine or iodine to obtain compound (IV). This reaction is preferably carried out in a solvent, for example, a lower alkanol, Hal is preferably bromine or iodine. The compound (IV) can be converted to the compound (V) by reaction with a strong base, e.g. sodium hydride or potassium t-butoxide. The reaction is preferably carried out in an inert polar solvent, for example tetrahydrofuranyl, methyl formamideo. for example, the boiling point of the reaction mixture is an alternative method for the preparation of intermediates where X is the group Q, S, B is 1,2-ethanediyl or 1,3 propanediyl, is the reaction of the compound (ill) with aziridine or azetidine or C-substituted It is produced in the form of a compound, L) in and the heating of this compound in the absence of a catalyst, for example, potassium, and a compound, is preferably carried out in a dry aprotic polar solvent, for example, acetone or 2-non. Intermediate compounds (II), g X group QS, and B - 2-aza-1,3-prodyl, can be obtained by reacting the same compound with formaldehyde and the amine R NH (Os NjX-H 54 Compounds (VII) can be prepared by reacting compound (III) with ammonia. Example 1, Z-fZ - ($ -methyl-4-dazolylmethylthio) ethyl amino-3-nitro-1, 5,6-tetrahydropyridine, a). A solution of sodium methylate (sodium 0.09 g (0.004 mol) in 10 methanol) is added dropwise to a stirred solution of 1-nitro-2-methylthio-2-methylsulfonyl-ethylene (0.5 g, 0.003 mol) and hydrochloride 3 bromopropylamine (0.9 g. O, CO mol) in methanol (30 ml) o The mixture is stirred for 5 h, and then the solvent is distilled off in vacuum. The residue is dissolved in water (20 ml) and extracted with chloroform (2-30 ml ). The extracts are combined, dried and concentrated in vacuo. The solid residue is recrystallized from propan-2-ol to give 1-nitro-2-methylthio-2- (3-bromopropylamino) ethylene (0.3 g,), m.p. 92-92 ,. Found,%: C 28.2; H 4.3; N10.9; S 12.5; Br 31.3. CfcH. Calculated,%; C 28.2; H, 35; N 11, 0; S 12.6; Br 31.3. c) o A mixture of 1-nitro-2-methylthio-2- (3-bromopropylamino) ethylene (3.2 g, 0.012 mol) and sodium hydrate (501 in oil, 0.9 g, 0.019 mol) in dry tetrahydrofuran (50 ml the mixture is filtered, and the filtrate is evaporated to dryness. The residue is chromatographed on a column filled with silica gel, the product is eluted with ethyl acetate. Recrystallization of the product from methanol with propan-2-ol gives 2-methylthio-3-nitro - 1 , 5 i6-tetrahydropyridine (0.6 g, 29), so pl. 230.5-231.5С. Found,%: C 41.5; H 5.7; N 16.1; S 18.25. , Calculated,%: C k, C; H 5.8; N 16.1; S 18, it, c). A solution of 2- (5 methyl - + - imidazolylmethylthio) ethylamine (0.51 g, 0.003 mol) and 2-methylthio-3-nitro-1, A, 5, 6-tetrahydropyridine (0.49 g, 0.003 mol) in ethanol (50 ml) is heated under reflux for 6 hours. The mixture is cooled and the solvent is distilled off in vacuo. The residue is dissolved in hot propan-2-ole, and the product is crystallized upon cooling. Recrystallization of the product from a mixture of propan-2-ol and methanol gives (5 methyl-α-imidazolylthio) ethylamino-3 nitro-1, +, 5,6 - tetrahydropyridine (0.66 g, 82), Topl. 205.5-206 ,, Found,%: C it8,6; H 6.5; N 23, S 10.8. C, .0, jS. Calculated: C 8.5; H 6, it; N 23.55; S 10,8, 2. 2-G2- (5-methyl- + Example - imidazolylmethylthio) ethylamino -3-nor po-t, 5 dihydropyrrole. but). A solution of 1-nitro-2-methylthio-2-methylsulfinylphenylene (2 g, 0.011 mol and aziridine (0.5 g. O, 0116 mol) in methanol (20 mol) is stirred at room temperature for 1 h. The solid, which crystallized, filtered off to obtain 1-nitro-2-methylthio-2-aziridinoethyl (1.3 g,), mp 107.5-PO ° C. The structure of the obtained compound was confirmed by NMR spectra. Nitrogen is passed for 15 minutes through a solution of 1-nitro-2-methyl-thio-2-aziridinoethylene (0.5 g, 0.003 mol) in dry acetone (15 ml) and the reaction mass is heated to 35 ° C. Potassium iodide (2.5 g, 0.015 mol) is added to the solution, resulting in the rapid formation of a heavy yellow precipitate. It is filtered off, washed with water and then with acetone, to obtain 2-methylthio-3-nitro-i, 5 dihydropyrrole (0.17 g,), Toplo 207-209 ° Co Found:%: C 37.3; H 4.9; N 17.3 S 19.75. : H8N ,. Higher;% C 37.5; 17.5; S 20.0. with). A solution of sodium methoxide (sodium 0.3 g, 0.013 mol) in methanol (10 ml) is added dropwise over 10 minutes to a stirred mixture of 1-nitro-2-methylthio-2-methylsulfinyl ethyl (2 g, 0.011 mol) and 2-bromoethylamine hydrobromide (2.7 g, 0, .013 mol) in methanol (25 ml), cooled to 0 ° C, stirred at 0 ° C for another 15 minutes, and then left to cool to room temperature . After 1 h, the solvent is removed in vacuo, the semi-solid residue is extracted with hot chloroform (2 × 25 ml). The extracts are combined and concentrated in vacuo. Solid 5 residue is recrystallized from propan-2-ol to give 1-nitro-2-methylthio-2- (2-Promethylamino) ethylene (1.85 g), mp. 123-126C. Found,%. C 25.1; And 3.7; N 11.8; S 13.6; Br 33.3. C5.HgBrN, 0, S. Calculated,%: C 2.9; H 3.8; N 11.6; S 13.3; Br 33.1. d). A solution of 1-nitro-2-methylthio-2- (2-bromoethylamino) ethylene (3 g, 0.012 mol) of sodium hydrate (50% in oil, 0.62 g, 0.013 mol) in dry tetrahydrofuran (100 ml) is heated with reflux for 7 m. The reaction mixture is cooled and the solvent is removed in vacuo. The residue is extracted with boiling ethyl acetate (250 ml) and the extracts are decolorized with charcoal. Concentration of the extracts in vacuo followed by cooling results in crystals of 2-methylthio-2-nitro-C, 5-dihydropyrrole (0.5 g, 26). e). A solution of 2- (5-methyl -} - imidazolylmethylthio) ethylamine (1.3 g, O, 0076 mol) and 2-methylthio-3-nitro, 5-dihydropyrrole (1.2 g, 0.0075 mol) in ethanol ( 50 ml) is heated under reflux for 1.5 hours. “The mixture is cooled, the solid is filtered and recrystallized from a mixture of methanol and water to obtain (5-methyl-imidazolylmethylthio) ethylamino-3-nitro, 5-dihydropyrrol ( 1, g, 66), t „pl, 207.5208 ° С. C, 46.65; H 6.15; Found, N 24.6; S 11.5. .-jNjOr S. C 46.6; H 6.05; Calculated% N 2 h, 7; S 11.3. Example 3. 1-Benzyl-4- 2- (5-methyl-4-imidazolylmethylthio) -ethylamino-5-nitro-1, 2,3-tetrahydropyrimidine. but). Aqueous ammonia (301 weight / weight, 9 ml, 0.16 mol) is added dropwise to a solution of 1-nitro-2-methylsulfinyl-2-methylthioethylene (20 g, 0.11 mol) in tetrahydrofuene (80 ml) at 50 ° C. The mixture was stirred at 50 ° C for 1 Cho. The solvent was removed in vacuo, and the residue was chromatographed on a silica gel column. The product was eluted with petroleum ether (b.p., OOB c) with ethyl acetate (10: 3) and recrystallized from ethyl acetate / petroleum ether to give 1-nitro-2-amino-2-methylthioethylene 1.5 g 10, (t pl, 109 -PO ° C). Found,%: C 27.1; And i4,5; N 20.7; S 23.7. . Calculated,%: C 2b, 9; H i, 5; N 20.9; S 23.9. at). Formaldehyde CtO w / w, 2 ml, 0.03 mol) and benzylamine (3 ml, 0.03 mol) are successively added to a stirred solution of 1-nitro-2-amino-2-methylthioethylene (1 g, 0.007 mol) in methanol (20 ml) “After 5 min, the solid was filtered off and recrystallized from methanol to give 1-benzyl-A-methylgio-5 nitro-1, 2,3,6-tetrahydropyridimidine (1.3 g, 70%), t. 173-173, Found,% i C 5.0; H 5.6; N 15.8; S 11.8. C Q H NjOuS. Calculated: C5,3; H 5.7; N 15.8; S 12.1. with). A solution of 1-benzyl-4-methylthio-5-nitro-1,2,3,6-tetrahydropyrimidine (1 g, 0.004 mol) and 2- (5-methyl-4-imidazolylmethylthio) ethylamine (0.7 g, 0, 00 mol) in methanol (kQ ml) is heated with stirring under a period of 10 Cho. The solvent is removed in vacuo and the residue is chromatographed on a column filled with silica gel. Elution with a mixture of ethyl acetate and propan-2-one (30%) of the product, which is recrystallized from a mixture of methanol and propan-2-ol, gives 1-benzyl-4- 2- (5-methyl- | -imidazolylthio) ethylamino-5- nitro-1, 2,3,6-tetrahydro pyrimidine (0.5 g, 32), mp. 177 -180. Found,%: C 55.5; H 6.3; N 21.4; S 8.0. Chv a4 b015 Calculated,%: C 55, b5; And 6.2; N 21.6; S 8.25. 58 The synthesized target products exhibit the activity of the histamine H Receptor antigonists and may be useful, for example, as anti-inflammatory agents of gastric acid release inhibitors, as agents acting on the cardiovascular system, namely inhibitors of the action of histamine on the blood pressure Formula of Invention A method of producing nitro compounds of general formula B Het-CH2-0-lCH2) 2HN where Het is imidazole substituted with lower alkyl; B is 1,2-ethanediyl, 1,3-propanediyl or 2-aza-1,3 propandiyl of the formula CHftNR CHn, where R is benzyl, characterized in that the compound of the general formula Het-CH ((CHQ), is NHQ, where the Net value is given above, is introduced into interaction with the compound of the general formula 1 where X is the QS group, in which Q is lower alkyl, and the values of B are given above and the target product is isolated. Sources of information taken into account in examination 1 Buhler K., Pearson D. Organic syntheses. M., 1973, t „1, pp. 515 516.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU888815A3|1981-12-07|Method of preparing nitrocompound
    FR2655988A1|1991-06-21|NOVEL NAPHTH-1-YL PIPERAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
    US4517197A|1985-05-14|-N-substituted phenyl-5-methoxymethyl-2-oxazolidinones and pharmaceutical compositions containing same
    SU906376A3|1982-02-15|Method for preparing 2-nitroaminopyramidone-4 derivatives
    US4032559A|1977-06-28|N,2-dicyanoacetimidates
    CZ299257B6|2008-05-28|Process for preparing morpholine derivatives
    CS271476B2|1990-10-12|Method of pyrimidine's new derivatives production
    SU950188A3|1982-08-07|Process for producing derivatives of 4|-mercaptomethylimidazoles
    GB2086379A|1982-05-12|Ethylenediamine derivatives
    KR840002007B1|1984-10-27|Process for the preparation of a furan derivative
    US4500527A|1985-02-19|Antihypertensive 4[|-oxyiminomethyl phenyl]-1,4-dihydropyridines
    US4025537A|1977-05-24|Preparation of 3-carboalkoxy or 3-alkanoyl furans
    US5112855A|1992-05-12|Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds and compositions
    US3109844A|1963-11-05|3-| pyrrolidines
    CA1286301C|1991-07-16|2,2'-bi-1h-imidazoles
    EP0303348B1|1992-01-08|2-amino-5-hydroxy-4-pyrimidones
    JP3047551B2|2000-05-29|Cyanopyrazine derivatives
    JP2578797B2|1997-02-05|Method for producing N- | formamides
    US3320272A|1967-05-16|Process for preparing z-alkoxycyclo-heptimidazole derivatives
    Shibuya et al.1975|Reaction of 1, 3-Oxazinium Salt with Active Methylene Compounds
    US5650511A|1997-07-22|Process for the preparation of 9-deazaguanine derivatives
    SU922108A1|1982-04-23|Process for producing derivatives of 6-methyl-8-beta-hydrazinomethylergolin or their salts
    US20210206746A1|2021-07-08|Novel processes for preparing a diaminopyrimidine derivative or acid addition salt thereof
    US4071684A|1978-01-31|Process for producing 3-substituted 1,2,4-triazines
    EP0003866B1|1981-11-04|3-azabicyclo|hexane derivatives and a process for their preparation
    同族专利:
    公开号 | 公开日
    HU181960B|1983-11-28|
    AR222999A1|1981-07-15|
    AT375367B|1984-07-25|
    NO151322B|1984-12-10|
    IE791099L|1979-11-30|
    ATA395179A|1983-12-15|
    EP0005984B1|1983-06-22|
    DD144057A5|1980-09-24|
    NO791763L|1979-12-03|
    IL57416D0|1979-09-30|
    ZA792608B|1980-06-25|
    PL215970A1|1980-02-11|
    AU522259B2|1982-05-27|
    GR68500B|1982-01-07|
    CA1118774A|1982-02-23|
    US4238493A|1980-12-09|
    EP0005984A1|1979-12-12|
    PL117921B1|1981-09-30|
    JPS54157584A|1979-12-12|
    NO151322C|1985-03-20|
    CS228116B2|1984-05-14|
    FI791737A|1979-12-01|
    PT69686A|1979-06-01|
    US4656176A|1987-04-07|
    BG31649A3|1982-02-15|
    RO78154A|1982-02-01|
    DK223979A|1979-12-01|
    YU127179A|1983-01-21|
    ES481076A1|1980-02-01|
    DE2965716D1|1983-07-28|
    IL57416A|1983-03-31|
    IE48510B1|1985-02-20|
    AU4758079A|1979-12-06|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3980781A|1966-03-31|1976-09-14|Imperial Chemical Industries Limited|Fungicidal composition and method containing 2-amino-pyrimidines|
    DE1617705C3|1966-12-19|1973-10-11|Oreal|Cosmetic product for hair treatment|
    GB1223686A|1967-02-24|1971-03-03|Ici Ltd|Salts of pyrimidine derivatives and the use thereof as fungicides|
    US3518251A|1967-06-07|1970-06-30|Geigy Ag J R|Certain aminoalkylamino substituted azacycloalkenes|
    BE758146A|1969-10-29|1971-04-28|Smith Kline French Lab|AMIDINE DERIVATIVES|
    US3968216A|1969-10-29|1976-07-06|Smith Kline & French Laboratories Limited|Method of inhibiting histamine activity with guanidine compounds|
    US3905984A|1971-03-09|1975-09-16|Smith Kline French Lab|Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas|
    US3950353A|1971-03-09|1976-04-13|Smith Kline & French Laboratories Limited|Pharmacologically active thiourea and urea compounds|
    US3920822A|1972-09-05|1975-11-18|Smith Kline French Lab|Inhibition of histamine activity with cyanoguanidines|
    US4005205A|1974-04-24|1977-01-25|Smith Kline & French Laboratories Limited|Compositions and methods for inhibiting H2 histamine receptors|
    GB1419994A|1973-05-03|1976-01-07|Smith Kline French Lab|Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them|
    GB1421792A|1973-05-17|1976-01-21|Smith Kline French Lab|Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them|
    CH595061A5|1974-05-10|1978-01-31|Ciba Geigy Ag|
    US4166856A|1975-05-21|1979-09-04|Smith Kline & French Laboratories Limited|Thiazole and isothiazole derivative as blockers of histamine H2 -receptors|
    GB1563090A|1975-07-31|1980-03-19|Smith Kline French Lab|Cyclobutene-diones|
    IN146736B|1975-10-02|1979-08-25|Smith Kline French Lab|
    US4297498A|1978-01-30|1981-10-27|Mead Johnson & Company|4-Tertiary-amino-2,6-diaminopyridine 1-oxides|
    US4154834A|1975-12-29|1979-05-15|Smith Kline & French Laboratories Limited|Substituted isocytosines having histamine H2 -antagonist activity|
    GB1565966A|1976-08-04|1980-04-23|Allen & Hanburys Ltd|Aminoalkyl furan derivatives|
    DE2752820A1|1977-11-26|1979-05-31|Bayer Ag|NEW NITRO-SUBSTITUTED 1,4-DIHYDROPYRIDINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT|
    ZA792608B|1978-05-30|1980-06-25|Smith Kline French Lab|Nitro compounds|US4525477A|1981-12-02|1985-06-25|Smith Kline & French Laboratories Limited|2-Thiazolyl, isothiazolyl, oxazolyl and isoxazolyl alkylamino-3-nitro-heterocyclic compounds|
    ZA792608B|1978-05-30|1980-06-25|Smith Kline French Lab|Nitro compounds|
    US4405624A|1978-05-30|1983-09-20|Smith Kline & French Laboratories Limited|Nitro-substituted dihydropyrroles and tetrahydropyridines, compositions, compounds, and medicinal use|
    IL61234A|1979-10-24|1984-03-30|Smith Kline French Lab|Guanidino thiazolyl alkylaminonitrotetrahydropyridines,process for preparing them and pharmaceutical compositions containing them|
    PT72320B|1980-01-08|1982-07-23|Glaxo Group Ltd|Process for preparation of a furan derivative|
    US4350696A|1980-03-08|1982-09-21|Pfizer Inc.|Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof|
    ZW21281A1|1980-10-01|1981-11-18|Smith Kline French Lab|Amine derivatives|
    US4439437A|1981-04-28|1984-03-27|Smith Kline & French Laboratories Limited|2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethylamino]-3-pyridines, compositions containing same and method of use|
    IE53068B1|1981-06-15|1988-05-25|Merck & Co Inc|Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors|
    PT75074B|1981-06-27|1986-02-26|Smith Kline French Lab|Process for preparing certain pyrimidone derivatives and compositions containing them|
    AU2222083A|1982-12-14|1984-06-21|Smith Kline & French Laboratories Limited|Pyridine derivatives|
    GR82004B|1983-06-30|1984-12-12|American Home Prod|
    IN170284B|1988-10-26|1992-03-07|Takeda Chemical Industries Ltd|
    EP0375613A3|1988-12-21|1990-11-28|Ciba-Geigy Ag|Nitroenamine|
    US6133291A|1998-10-16|2000-10-17|Schering Corporation|N-substituted cyclic amines as histamine-H3 agonists or antagonists|
    WO2022034121A1|2020-08-11|2022-02-17|Université De Strasbourg|H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    GB2411678|1978-05-30|
    [返回顶部]